Sun Pharmaceutical Industries announces voluntary withdrawal of 28 ANDAs
Drug Major, Sun Pharmaceuticals informed BSE on Tuesday that one of the Company’s wholly-owned subsidiaries has voluntarily requested the USFDA to withdraw approval for 28 Abbreviated New Drug Applications (ANDAs) ) as they belonged to older drug products of erstwhile Ranbaxy Laboratories and are not being…